Fifth Third Bancorp’s Standard BioTools LAB Stock Holding History

Fifth Third Bancorp’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.07K	Buy	+2,254	New	+$2.73K	﹤0.01%	4029
2018 Q3	–	Sell	-516	Closed	-$3K	–	2255
2018 Q2	$3K	Hold	516	–	–	﹤0.01%	2133
2018 Q1	$3K	Hold	516	–	–	﹤0.01%	2130
2017 Q4	$3K	Hold	516	–	–	﹤0.01%	2087
2017 Q3	$3K	Hold	516	–	–	﹤0.01%	2001
2017 Q2	$2K	Hold	516	–	–	﹤0.01%	2050
2017 Q1	$3K	Hold	516	–	–	﹤0.01%	1932
2016 Q4	$4K	Hold	516	–	–	﹤0.01%	1962
2016 Q3	$4K	Buy	+516	New	+$4.74K	﹤0.01%	2012

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fifth Third Bancorp's LAB Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in Standard BioTools (LAB) in Q1 2026: 2,254 shares worth $2.07K. The stake represents ﹤0.01% of the portfolio and ranks #4029 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in LAB as recently as Q2 2018.

Fifth Third Bancorp first reported a position in LAB in Q3 2016 and has held it in 9 quarters since. The position peaked at $4K in Q4 2016. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

Fifth Third Bancorp held 2,254 shares of Standard BioTools worth $2.07K as of Q1 2026.
Standard BioTools was a new Fifth Third Bancorp position in Q1 2026.
Standard BioTools made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #4029 holding.
Fifth Third Bancorp first reported a position in Standard BioTools in Q3 2016 and has held it in 9 quarters since.
Fifth Third Bancorp's Standard BioTools position peaked at $4K in Q4 2016.
155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.